Efficacy and Safety of Remimazolam (CNS7056) Compared to Propofol for Intravenous Anesthesia During Elective Surgery
Status:
Completed
Trial end date:
2020-04-02
Target enrollment:
Participant gender:
Summary
A phase III confirmatory trial evaluating the efficacy and safety of remimazolam (CNS7056)
compared to propofol for intravenous anesthesia during elective surgery in ASA Class III/IV
patients.
Phase:
Phase 3
Details
Lead Sponsor:
Paion UK Ltd.
Collaborators:
Creative Clinical Research GmbH ORION Clinical Services Simbec Research